Extraction amd clinical determination of pancreatic tissue carcinoma antigen

Expression of tissue factor antigen in different kinds of human cancer

组织因子在不同类型人癌组织中的表达

In this study, it also has been shown that blocking endogenous biotin is not a necessary procedure in detecting tissue antigen on paraffin embeded section.

本研究还发现，检测石蜡切片肝组织内抗原时，阻断内源性生物素并不是一个必不可少的步骤。

Effects of nitric oxide on proliferation, apoptosis of pulmonary circulatory tissue cells in chronic anoxia rats

一氧化氮对慢性低氧大鼠肺循环组织细胞增殖/凋亡的影响

Angiogenesis is the process that new capillaries from existing vessel are formed by sprouting, migration, proliferation of endothelial cell ( EC) and extracellular matrix remodelling during wound healing, inflammation, ischemia and tissue anoxia.

血管生成（angiogenesis）是指机体在发育过程中或创伤修复、缺血缺氧和炎症等情况下，原有内皮细胞（Endothelial Cell，EC）经过出芽、迁移、增殖与基质重塑等形成新生毛细血管的过程。

Hence the author suggests:# ( 1) The microcirculation of the patients with asthma have evident pathological changes which influence the gas exchanges in the lungs, the tissues and the cells, resulting in tissue anoxia.

作者认为：（1）哮喘患者微循环有明显的病理改变，这些病理改变影响肺以及组织、细胞的气体交换，是造成患者织组缺氧的原因之一；

It is indicated that 654& 2 plays an important role in improving microcirculation and tissue anoxia, increasing local blood supply and promoting wound healing.

提示654&2有改善微循环、增加局部血供、减轻组织缺氧、促进创面修复的作用。

Objective To verify the diagnostic action of the deep-picture analysis of blood oxygen in children with tissue anoxia.

目的探索血氧深入图像分析技术对患儿组织缺氧的判断作用。

Objective To evaluate the effects of ultrasound irradiation on tissue plasminogen activator ( TPA) fibrinolysis in vitro.

目的评价在体外实验条件下，超声波辐照对组织型纤溶酶原激活物（TPA）溶栓效率的促进作用。

Treatment of intraocular fibrinous membrane by anterior chamber injection of tissue plasminogen activator after IOL implantation

t-PA前房注射治疗人工晶体植入术后纤维蛋白性膜

Roles of tissue plasminogen activator in epidermal stratification

tPA对表皮角质形成细胞分层的影响

Alterations in plasma levels of tissue plasminogen activator and its inhibitor after venous occlusion in normal subjects

正常人静脉血流阻断后血浆组织型纤溶酶原激活剂含量、活性及其抑制物活性的变化

Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test

重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较

Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction;

目的探讨静脉溶栓对男女急性心肌梗塞患者的疗效对比。

The Changes of Plasma Tissue Plasminogen Activator and its Inhibitor Activity and Collagen Turnover during Vascular Restenosis Development

血管再狭窄发生过程中血浆组织型纤溶酶原激活物及其抑制剂活性与胶原转换的变化

Optimizing discharge planning: Clinical predictors of longer stay after recombinant tissue plasminogen activator for acute stroke

最佳出院计划：重组组织型纤溶酶原激活剂治疗急性卒中后长时间住院的临床预测因素

Regulation of tissue plasminogen activator expression by EGF in epidermal keratinocytes of mouse

EGF对小鼠角质形成细胞中组织型纤溶酶原激活剂表达的调节

Clinical Analysis of Recombinant Tissue Plasminogen Activator on the Treatment of Ultra-acute Cerebral Infarction in Beijing Area

北京地区rt-PA静脉溶栓治疗超早期脑梗死患者临床分析

Effects of tissue plasminogen activator ( t-PA) on scar formation after experimental filtration surgery

组织型纤溶酶原激活剂（t-PA）对实验性青光眼滤过性手术瘢痕形成的影响

Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke

重组型组织纤溶酶原激活剂治疗急性缺血性卒中后的止血激活和临床预后

The Relationship of Tissue Plasminogen Activator and Inhibitor Activity Levels with Insulin Resistance in NIDDM Patient

NIDDM病人血浆组织型纤溶酶原激活物及其抑制物的活性水平与胰岛素抵抗关系的探讨